EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states



Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states



Journal of the American Medical Association 157(18): 1596-1598




(PDF emailed within 0-6 h: $19.90)

Accession: 050427184

Download citation: RISBibTeXText

PMID: 14367013

DOI: 10.1001/jama.1955.02950350010005



Related references

Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 87(3): 608-610, 1954

Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate). Journal of the American Medical Association 157(18): 1594-1596, 1955

Nonthrombocytopenic purpura due to Miltown (2-methyl-2-N-propyl-1, 3 propanediol dicarbamate). New England Journal of Medicine 255(16): 770-771, 1956

A clinical evaluation of miltown (2 methyl-2-N-propyl-1, 3 propanediol dicarbamate). New York State Journal of Medicine 57(12): 2060-2060, 1957

Toxic reaction to 2-methyl-2-n-propyl-1, 3, propanediol dicarbamate (miltown and equanil). Annals of Internal Medicine 46(5): 1002-1004, 1957

The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent. Journal of Pharmacology and Experimental Therapeutics 112(4): 413-423, 1954

Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate). Rassegna di Neuropsichiatria E Scienze Affini 11(3-4): 145-171, 1957

The effect of 2-methyl 2-n-propyl-13-propanediol dicarbamate on the central nervous system. 1954

Effect of 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate) on the spinal electric potential in frogs. Archivio Italiano di Scienze Farmacologiche 8(1): 74-84, 1958

Could methyl-2-N-propyl-2-propandiolo-1,3-dicarbamate (meprobamate, miltown, perequil) be ultimately used in chronic lead poisoning?. Folia Medica. Folia Medica 42: 819-824, 1959

Effect of continuous supplementation of concentrates with 2-methyl-2-propyl-1, 3 propanediol (1) dicarbamate on index of transformation in pigs. Revista de Nutricion Animal. 9: 4, 209-213, 1971

Use of 2-methyl-2-N-propyl-1, 3-propanediol dicarbamate in psychiatry. Minerva Medica 47(88): 1455-1457, 1956

Methyl-propyl-propanediol dicarbamate (meprobamate) in dermatology. Minerva Medica 47(88): 1478-1480, 1956

Pharmacological studies of 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate. Bollettino Della Societa Italiana di Biologia Sperimentale 32(12): 1461-1463, 1956